MktsMarkets

Altimmune, Inc.
NASDAQ: ALTKey statistics
ALT News
Stories mentioning ALT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 26.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 16,192 | 18,409 | 14,960 | 17,236 | 15,827 | 19,781 | 19,803 | 21,155 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 24,244 | 28,919 | 20,864 | 22,927 | 21,820 | 24,871 | 24,772 | 26,750 |
| Operating Income (Loss) | (24,244) | (28,893) | (20,859) | (22,922) | (21,815) | (24,866) | (24,767) | (26,745) |
| Interest Income | 2,901 | 2,438 | 2,426 | 1,132 | 1,545 | 1,569 | 1,910 | 2,182 |
| Interest Expense | ||||||||
| Other Expense | (152.00) | (27.00) | (86.00) | (92.00) | 15.00 | 118.00 | 18.00 | (76.00) |
| Pretax Income | (22,563) | (27,358) | (19,014) | (22,146) | (20,256) | (23,180) | (22,845) | (24,640) |
| Tax Provision | (681.00) | 0.00 | 0.00 | |||||
| Net Income (Loss) | (22,563) | (27,358) | (19,014) | (22,146) | (19,575) | (23,180) | (22,845) | (24,640) |
| Earnings Per Share (Basic) | (0.18) | (0.31) | (0.21) | (0.27) | (0.26) | (0.33) | (0.32) | (0.35) |
| Earnings Per Share (Diluted) | (0.18) | (0.31) | (0.21) | (0.27) | (0.26) | (0.33) | (0.32) | (0.35) |
| Weighted Average Shares Outstanding (Basic) | 124,462 | 88,104 | 89,418 | 81,478 | 75,548 | 71,003 | 71,085 | 70,924 |
| Weighted Average Shares Outstanding (Diluted) | 124,462 | 88,104 | 89,418 | 81,478 | 75,548 | 71,003 | 71,085 | 70,924 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ALT
Altimmune, Inc. (NASDAQ: ALT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALT. It last traded at $1.32 (Nov 20, 2026, 9:30 AM ET), down 6.4% on the day. That gives Altimmune a market capitalisation of $262.7M.
Over the past 52 weeks ALT has traded between $1.32 and $6.44.
For the quarter ended Mar 31, 2026 it reported a net loss of $22.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$22.6M | — |
| Dec 31, 2025 | $26.0K | -$27.4M | -105223.1% |
| Sep 30, 2025 | $5.0K | -$19.0M | -380280.0% |
| Jun 30, 2025 | $5.0K | -$22.1M | -442920.0% |
From Altimmune’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…